TLT:LYX
$0.205
-
0.00%
Theralase Technologies Inc.News & Events
Last updated: Aug 1, 2025, 9:23 AM ET
Theralase(R) Closes Non-Brokered Private Placement
Newsfile JUL 28, 2025 7:00 AM EDTToronto, Ontario--(Newsfile Corp. - July 28, 2025) - Theralase® Technologies Inc. (TSX...READ ARTICLETheralase(R) Extends Warrants
Newsfile JUN 27, 2025 4:30 PM EDTToronto, Ontario--(Newsfile Corp. - June 27, 2025) - Theralase ® Technologies Inc. (T...READ ARTICLETheralase(R) Closes Non-Brokered Private Placement
Newsfile JUN 17, 2025 7:00 AM EDTToronto, Ontario--(Newsfile Corp. - June 17, 2025) - Theralase® Technologies Inc. (TSX...READ ARTICLETheralase Completes Annual General and Special Meeting
Newsfile JUN 12, 2025 7:00 AM EDTToronto, Ontario--(Newsfile Corp. - June 12, 2025) - Theralase® Technologies Inc. ...READ ARTICLETheralase Annual General Meeting
Newsfile JUN 5, 2025 7:00 AM EDTToronto, Ontario--(Newsfile Corp. - June 5, 2025) - Theralase® Technologies Inc. (TSXV: TLT...READ ARTICLETheralase(R) 1Q2025 Financial Statements
Newsfile MAY 30, 2025 7:00 AM EDTToronto, Ontario--(Newsfile Corp. - May 30, 2025) - Theralase® Technologies Inc. ( TSXV: TLT...READ ARTICLECORRECTION FROM SOURCE: Theralase to Present Groundbreaking Research at ASTRO 2025
Newsfile MAY 29, 2025 4:30 PM EDTRadiation-Activated Rutherrin(R) Versus Radiation Alone in Preclinical Cancer Models to be Presen...READ ARTICLETheralase to Present Groundbreaking Research at ASTRO 2025
Newsfile MAY 28, 2025 7:00 AM EDTRadiation-Activated Rutherrin(R) Shown to Be 100 Times More Effective Than Radiation Alone in Pre...READ ARTICLETheralase Provides Corporate Update
Newsfile MAY 20, 2025 7:00 AM EDTToronto, Ontario--(Newsfile Corp. - May 20, 2025) - Theralase® Technologies Inc. (TSXV: TLT...READ ARTICLETheralase Clinical Data Presented at Canadian Bladder Cancer Forum and American Urological Association
Newsfile MAY 5, 2025 7:00 AM EDTToronto, Ontario--(Newsfile Corp. - May 5, 2025) - Theralase® Technologies Inc. (TSXV: TLT)...READ ARTICLE